Literature DB >> 30391206

MDM2 and mitochondrial function: One complex intersection.

Camila Rubio-Patiño1, Andrew Paul Trotta1, Jerry Edward Chipuk2.   

Abstract

Decades of research reveal that MDM2 participates in cellular processes ranging from macro-molecular metabolism to cancer signaling mechanisms. Two recent studies uncovered a new role for MDM2 in mitochondrial bioenergetics. Through the negative regulation of NDUFS1 (NADH:ubiquinone oxidoreductase 75 kDa Fe-S protein 1) and MT-ND6 (NADH dehydrogenase 6), MDM2 decreases the function and efficiency of Complex I (CI). These observations propose several important questions: (1) Where does MDM2 affect CI activity? (2) What are the cellular consequences of MDM2-mediated regulation of CI? (3) What are the physiological implications of these interactions? Here, we will address these questions and position these observations within the MDM2 literature.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Apoptosis; Bioenergetics; Complex I; Electron transport chain; MDM2; Mitochondria; Oncogene; Tumor suppressor; p53

Mesh:

Substances:

Year:  2018        PMID: 30391206      PMCID: PMC6448155          DOI: 10.1016/j.bcp.2018.10.032

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  55 in total

Review 1.  Mitochondrial protein import: from proteomics to functional mechanisms.

Authors:  Oliver Schmidt; Nikolaus Pfanner; Chris Meisinger
Journal:  Nat Rev Mol Cell Biol       Date:  2010-09       Impact factor: 94.444

Review 2.  Building a complex complex: Assembly of mitochondrial respiratory chain complex I.

Authors:  Luke E Formosa; Marris G Dibley; David A Stroud; Michael T Ryan
Journal:  Semin Cell Dev Biol       Date:  2017-08-07       Impact factor: 7.727

Review 3.  The mitochondrial electron transport and oxidative phosphorylation system.

Authors:  Y Hatefi
Journal:  Annu Rev Biochem       Date:  1985       Impact factor: 23.643

4.  MDM2 overexpression generates a skin phenotype in both wild type and p53 null mice.

Authors:  M Alkhalaf; G Ganguli; N Messaddeq; M Le Meur; B Wasylyk
Journal:  Oncogene       Date:  1999-02-18       Impact factor: 9.867

5.  Overexpression of mouse Mdm2 induces developmental phenotypes in Drosophila.

Authors:  Adriana Folberg-Blum; Amir Sapir; Ben-Zion Shilo; Moshe Oren
Journal:  Oncogene       Date:  2002-04-04       Impact factor: 9.867

6.  Rescue of embryonic lethality in Mdm2-deficient mice by absence of p53.

Authors:  S N Jones; A E Roe; L A Donehower; A Bradley
Journal:  Nature       Date:  1995-11-09       Impact factor: 49.962

7.  Isolation and inactivation of the nuclear gene encoding the rotenone-insensitive internal NADH: ubiquinone oxidoreductase of mitochondria from Saccharomyces cerevisiae.

Authors:  C A Marres; S de Vries; L A Grivell
Journal:  Eur J Biochem       Date:  1991-02-14

8.  Mitochondrial MDM2 Regulates Respiratory Complex I Activity Independently of p53.

Authors:  Giuseppe Arena; Madi Yann Cissé; Samuel Pyrdziak; Laurent Chatre; Romain Riscal; Maryse Fuentes; Jamie Jon Arnold; Markus Kastner; Laurie Gayte; Christelle Bertrand-Gaday; Kevin Nay; Claire Angebault-Prouteau; Kerren Murray; Beatrice Chabi; Christelle Koechlin-Ramonatxo; Béatrice Orsetti; Charles Vincent; François Casas; Jean-Christophe Marine; Sandrine Etienne-Manneville; Florence Bernex; Anne Lombès; Craig Eugene Cameron; Hervé Dubouchaud; Miria Ricchetti; Laetitia Karine Linares; Laurent Le Cam
Journal:  Mol Cell       Date:  2018-02-15       Impact factor: 17.970

9.  In vivo activation of the p53 pathway by small-molecule antagonists of MDM2.

Authors:  Lyubomir T Vassilev; Binh T Vu; Bradford Graves; Daisy Carvajal; Frank Podlaski; Zoran Filipovic; Norman Kong; Ursula Kammlott; Christine Lukacs; Christian Klein; Nader Fotouhi; Emily A Liu
Journal:  Science       Date:  2004-01-02       Impact factor: 47.728

10.  MDM2 gene amplification and expression in non-small-cell lung cancer: immunohistochemical expression of its protein is a favourable prognostic marker in patients without p53 protein accumulation.

Authors:  M Higashiyama; O Doi; K Kodama; H Yokouchi; T Kasugai; S Ishiguro; K Takami; T Nakayama; I Nishisho
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

View more
  4 in total

1.  MDM2 Integrates Cellular Respiration and Apoptotic Signaling through NDUFS1 and the Mitochondrial Network.

Authors:  Rana Elkholi; Ioana Abraham-Enachescu; Andrew P Trotta; Camila Rubio-Patiño; Jarvier N Mohammed; Mark P A Luna-Vargas; Jesse D Gelles; Joshua R Kaminetsky; Madhavika N Serasinghe; Cindy Zou; Sumaira Ali; Gavin P McStay; Cathie M Pfleger; Jerry Edward Chipuk
Journal:  Mol Cell       Date:  2019-03-14       Impact factor: 17.970

2.  Complex I and MDM2: hit me baby one more time.

Authors:  Jerry Edward Chipuk
Journal:  Mol Cell Oncol       Date:  2019-05-10

3.  MDM2-Mediated Ubiquitination of RXRβ Contributes to Mitochondrial Damage and Related Inflammation in Atherosclerosis.

Authors:  Yi Zeng; Ji Cao; Chun-Xia Li; Chun-Yan Wang; Ruo-Man Wu; Xiao-Le Xu
Journal:  Int J Mol Sci       Date:  2022-05-21       Impact factor: 6.208

Review 4.  Resistance mechanisms to inhibitors of p53-MDM2 interactions in cancer therapy: can we overcome them?

Authors:  Lucia Haronikova; Ondrej Bonczek; Pavlina Zatloukalova; Filip Kokas-Zavadil; Martina Kucerikova; Philip J Coates; Robin Fahraeus; Borivoj Vojtesek
Journal:  Cell Mol Biol Lett       Date:  2021-12-15       Impact factor: 5.787

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.